COLOR BRAC2 Dna Genetic Hereditary Breast Ovarian Cancer Kit Risk BRAC1

( Brand: Color ), ( Part Type: Breast Kit Test )

Review COLOR Dna Genetic Hereditary Breast Ovarian Cancer Risk Test Kit

The DNA Genetic Hereditary BRCA1 BRCA2 Breast Ovarian Cancer Risk Kit is a revolutionary tool designed to provide individuals with insight into their genetic predisposition towards breast and ovarian cancer. This at-home test kit utilizes advanced genetic analysis to evaluate the presence of mutations in the BRCA1 and BRCA2 genes, which are known to significantly increase the risk of developing these types of cancers.

The process is simple and non-invasive, requiring only a saliva sample collected using a provided kit. Once the sample is collected and sent to the laboratory, the DNA is extracted and analyzed for the presence of specific mutations. Results are typically available within 2-3 weeks after the lab receives the sample.

The report provided with the results is detailed and easy to understand, explaining whether any mutations were found in the BRCA1 or BRCA2 genes. If mutations are detected, the report will provide information on the specific type of mutation and its associated risk level. It's important to note that a positive result does not mean that cancer will definitely develop, but it does increase the likelihood and may influence prevention strategies and medical management options.

The DNA Genetic Hereditary BRCA1 BRCA2 Breast Ovarian Cancer Risk Kit is a valuable tool for individuals with a family history of breast or ovarian cancer, or for those who simply want to take proactive steps towards understanding their genetic health. It provides peace of mind and empowers individuals to make informed decisions about their health and future.

1. Personalized information: The kit can provide you with information about your genetic predisposition to breast and ovarian cancer, which can help you make informed decisions about your health.

2. Early detection and prevention: If the test reveals a high risk of developing breast or ovarian cancer, you can take preventive measures such as regular screenings, lifestyle changes, or even surgery to reduce your risk.

3. Peace of mind: Knowing your genetic risk can help reduce anxiety and provide a sense of control over your health.

1. Cost: The test can be expensive, ranging from several hundred to several thousand dollars.

2. Emotional impact: The test results can be emotionally charged and may lead to anxiety or stress.

3. False positives and negatives: The test is not 100% accurate, and there is a chance of false positive or negative results.

Conclusion: Buying a DNA genetic hereditary BRCA1/BRCA2 breast and ovarian cancer risk kit can provide you with valuable information about your genetic predisposition to breast and ovarian cancer. However, it is important to consider the cost, emotional impact, and the possibility of false results before making a decision. If you have a family history of breast or ovarian cancer or if you are at a high risk, the benefits of the test may outweigh the drawbacks. It is always recommended to consult with a healthcare professional before making a decision.

Recommendation: If you are considering buying a DNA genetic hereditary BRCA1/BRCA2 breast and ovarian cancer risk kit, it is important to do your research and consult with a healthcare professional. They can help you understand the risks and benefits of the test and provide guidance on how to interpret the results. Additionally, it is important to remember that genetic testing is just one piece of the puzzle when it comes to breast and ovarian cancer risk. Regular screenings, lifestyle changes, and regular check-ups are also important for maintaining good health.

Details:

All come from a smoke free household. I do combine shipping.

Color dna genetic hereditary BRAC1 BRAC2 breast ovarian cancer risk test kit one new about the product simple 30 gene test, including RCA 1 and RCA 2, to learn your for provide a saliva sample from convenience of home postage included, as well all lab fees.

Its simple, please only bid if you plan to pay.

part #: brac2 prices

• $29.99-$40.51

specifications medicalmonitori:

• brand: Color
• part type: Breast Kit Test

Seller medicalmonitori:

• zipcode: 64083
• city: Raymore, Missouri

Ratings:

1. All good 07-13-18
2. Fast and exactly as discribed 07-14-18
3. Thank you! Wonderful doing business with you! 07-15-18
4. Excellent 07-13-18
5. Thank you! 07-15-18

Returns medicalmonitori:

• policy: no returns

General medicalmonitori:

• in stock: Yes
• condition: New
• healthbeauty > medical mobilitydisability > monitoringtesting > other medical monitoring monitoring testing

Shipping medicalmonitori:

• type: Calculated
• handling: 3 days

Offer medicalmonitori:

• best offer: false
• Sold: 0
• quantity: 9
• bids: 0
• Started: July 15, 2018, 8:33 am

Payments medicalmonitori:

• PayPal

Color BRAC1 Is Similar To:

• 78255 Color Genomics Brca Testing Kit Breast Cancer Test 689816978255 (51.7% similar) Provide a saliva sample from the convenience of your home. Speak with our board-certified genetic counselors, at no extra cost, to help you understand your results. Your satisfaction is our 1 priority. This matters because you get a more complete picture of your RCA genes. Our test looks for all 2,...(September 14th, 2018)
• B075km3hhj Color Brca Test Genetic For Breast And Ovarian Cancer Risk (62.9% similar) Color - RCA test genetic for breast and ovarian cancer risk item is new but the box does have some wear to it see pictures...(July 18th, 2018)
• Mymold Detective Mold Test Kit Reusable Air Sampling Pump Color-coded Reports (23.8% similar) ...(November 3rd, 2022)
• Medline 080196169934 Compli-mate Dual Head Aneroid Sphygmomanometer Combination Kit 7 Color (9.7% similar) The product must be in new or unused condition, with all original inserts and accessories. Create the perfect environment for any occasion with bed bath beyond stylish range of home essentials. Hunter green. Materials nylon case. About: bed bath beyond is committed to being the destination for home ...(November 1st, 2024)